Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
Nat Commun. 2021 May 11;12(1):2670. doi: 10.1038/s41467-021-22958-8.
Nat Commun. 2021.
PMID: 33976165
Free PMC article.